Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Olive

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Biorxiv : the Preprint Server for Biology|January 18, 2024
Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of pancreatic ductal adenocarcinomaAlexander G Raufi, Ilenia Pellicciotta, Carmine F Palermo, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinomaMaryam Safari, Luigi Scotto, Agnes Basseville, et al.
Cancer Chemotherapy and Pharmacology|March 25, 2011
A novel method for quantification of gemcitabine and its metabolites 2',2'-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS/MS: comparison with (19)F NMR spectroscopyTashinga E Bapiro, Frances M Richards, Mae A Goldgraben, et al.
Cancer Research|August 21, 2020
A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic CancerTamas A Gonda, Jarwei Fang, Martha Salas, et al.
Cancer Research|September 17, 2005
Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer developmentSusan W P Wijnhoven, Edwin Zwart, Ewoud N Speksnijder, et al.
Gastroenterology|September 4, 2013
Identification and manipulation of biliary metaplasia in pancreatic tumorsKathleen E Delgiorno, Jason C Hall, Kenneth K Takeuchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2019
Effective Delivery of a Microtubule Polymerization Inhibitor Synergizes with Standard Regimens in Models of Pancreatic Ductal AdenocarcinomaJaime A Eberle-Singh, Irina Sagalovskiy, H Carlo Maurer, et al.
Therapeutic Advances in Medical Oncology|June 18, 2019
Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatmentTessa Ya Sung Le Large, Btissame El Hassouni, Niccola Funel, et al.
Cancers|April 3, 2021
Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of a Spontaneous Mouse Model of Pancreatic CancerBrittany J Poelaert, Shelby M Knoche, Alaina C Larson, et al.
Nature Cancer|March 27, 2023
Specific regulation of BACH1 by the hotspot mutant p53<sup>R175H</sup> reveals a distinct gain-of-function mechanismZhenyi Su, Ning Kon, Jingjie Yi, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Biorxiv : the Preprint Server for Biology|January 18, 2024
Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of pancreatic ductal adenocarcinomaAlexander G Raufi, Ilenia Pellicciotta, Carmine F Palermo, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinomaMaryam Safari, Luigi Scotto, Agnes Basseville, et al.
Cancer Chemotherapy and Pharmacology|March 25, 2011
A novel method for quantification of gemcitabine and its metabolites 2',2'-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS/MS: comparison with (19)F NMR spectroscopyTashinga E Bapiro, Frances M Richards, Mae A Goldgraben, et al.
Cancer Research|August 21, 2020
A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic CancerTamas A Gonda, Jarwei Fang, Martha Salas, et al.
Cancer Research|September 17, 2005
Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer developmentSusan W P Wijnhoven, Edwin Zwart, Ewoud N Speksnijder, et al.
Gastroenterology|September 4, 2013
Identification and manipulation of biliary metaplasia in pancreatic tumorsKathleen E Delgiorno, Jason C Hall, Kenneth K Takeuchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2019
Effective Delivery of a Microtubule Polymerization Inhibitor Synergizes with Standard Regimens in Models of Pancreatic Ductal AdenocarcinomaJaime A Eberle-Singh, Irina Sagalovskiy, H Carlo Maurer, et al.
Therapeutic Advances in Medical Oncology|June 18, 2019
Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatmentTessa Ya Sung Le Large, Btissame El Hassouni, Niccola Funel, et al.
Cancers|April 3, 2021
Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of a Spontaneous Mouse Model of Pancreatic CancerBrittany J Poelaert, Shelby M Knoche, Alaina C Larson, et al.
Nature Cancer|March 27, 2023
Specific regulation of BACH1 by the hotspot mutant p53<sup>R175H</sup> reveals a distinct gain-of-function mechanismZhenyi Su, Ning Kon, Jingjie Yi, et al.
Pageof 13